CNOT10 inhibitors belong to a class of chemical compounds that target the CNOT10 protein, which is a part of the CCR4-NOT complex. This complex is a multi-subunit structure that plays a critical role in regulating gene expression at the post-transcriptional level, particularly in mRNA degradation. CNOT10 is thought to contribute to the structural stability of the CCR4-NOT complex and assists in maintaining the proper function of other subunits. Inhibition of CNOT10 disrupts the overall activity of the CCR4-NOT complex, which can lead to alterations in mRNA decay rates. This, in turn, affects the availability of various proteins within the cell, particularly those involved in processes like cell cycle regulation, DNA repair, and signal transduction.
The mechanism by which CNOT10 inhibitors operate centers on their ability to bind to CNOT10, thereby interfering with its interaction with other components of the CCR4-NOT complex. By disrupting this interaction, these inhibitors can cause a downstream effect on gene expression profiles and cellular processes that depend on fine-tuned mRNA degradation. Given the role of the CCR4-NOT complex in multiple cellular pathways, CNOT10 inhibitors can influence a wide range of biological activities. They are therefore of great interest in biochemical research, particularly in studying gene regulation and the dynamics of post-transcriptional control mechanisms. Researchers use these inhibitors to gain deeper insights into how the CCR4-NOT complex, and specifically CNOT10, modulates the stability and decay of mRNAs across different cellular contexts.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Intercalates DNA, inhibiting RNA synthesis. By inhibiting RNA synthesis, it affects mRNA metabolism, potentially influencing CNOT10's function. | ||||||
DRB | 53-85-0 | sc-200581 sc-200581A sc-200581B sc-200581C | 10 mg 50 mg 100 mg 250 mg | $43.00 $189.00 $316.00 $663.00 | 6 | |
Inhibits RNA polymerase II, thereby suppressing transcription. This affects mRNA metabolism, which can indirectly influence the CNOT10 function. | ||||||
α-Amanitin | 23109-05-9 | sc-202440 sc-202440A | 1 mg 5 mg | $269.00 $1050.00 | 26 | |
Specifically inhibits RNA polymerase II, halting mRNA synthesis. This can indirectly modulate the CNOT10 function within the cell. | ||||||
Cordycepin | 73-03-0 | sc-203902 | 10 mg | $101.00 | 5 | |
Analog of adenosine. Incorporation during RNA synthesis leads to premature termination, affecting mRNA metabolism, which can impact CNOT10. | ||||||
Isoginkgetin | 548-19-6 | sc-507430 | 5 mg | $225.00 | ||
Inhibits spliceosome assembly, affecting pre-mRNA splicing. This can indirectly influence the function of CNOT10 in mRNA metabolism. | ||||||
Pladienolide B | 445493-23-2 | sc-391691 sc-391691B sc-391691A sc-391691C sc-391691D sc-391691E | 0.5 mg 10 mg 20 mg 50 mg 100 mg 5 mg | $299.00 $5699.00 $11099.00 $25500.00 $66300.00 $2875.00 | 63 | |
Binds to SF3B1, a splicing factor, and inhibits splicing. This can affect mRNA processing, indirectly impacting CNOT10. | ||||||
Flavopiridol Hydrochloride | 131740-09-5 | sc-207687 | 10 mg | $317.00 | ||
Inhibits cyclin-dependent kinase 9 (CDK9), affecting transcription elongation. This can indirectly influence the function of CNOT10. | ||||||
Triptolide | 38748-32-2 | sc-200122 sc-200122A | 1 mg 5 mg | $90.00 $204.00 | 13 | |
Inhibits RNA polymerase II-mediated transcription. This can influence mRNA metabolism processes where CNOT10 might play a role. | ||||||
Spliceostatin A | 391611-36-2 | sc-507481 | 1 mg | $1800.00 | ||
Binds to SF3B1, a component of the spliceosome, and affects mRNA splicing. This can indirectly impact CNOT10's function in mRNA metabolism. | ||||||
1,10-Phenanthroline | 66-71-7 | sc-255888 sc-255888A | 2.5 g 5 g | $23.00 $32.00 | ||
Chelates metal ions, which are crucial for many enzymes in RNA processing. This can potentially modulate CNOT10's role in mRNA metabolism. | ||||||